Macroview Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-97
| Closed | -$11.2K | – | 366 |
|
|
2024
Q3 | $11.2K | Buy |
97
+74
| +322% | +$8.53K | 0.01% | 219 |
|
|
2024
Q2 | $3.17K | Hold |
23
| – | – | ﹤0.01% | 426 |
|
|
2024
Q1 | $3.17K | Hold |
23
| – | – | ﹤0.01% | 466 |
|
|
2023
Q4 | $3.03K | Sell |
23
-73
| -76% | -$9.62K | ﹤0.01% | 456 |
|
|
2023
Q3 | $10.8K | Buy |
96
+88
| +1,100% | +$9.9K | 0.01% | 237 |
|
|
2023
Q2 | $755 | Hold |
8
| – | – | ﹤0.01% | 434 |
|
|
2023
Q1 | $810 | Sell |
8
-105
| -93% | -$10.6K | ﹤0.01% | 389 |
|
|
2022
Q4 | $13.5K | Hold |
113
| – | – | 0.02% | 159 |
|
|
2022
Q3 | $12K | Buy |
113
+105
| +1,313% | +$11.2K | 0.02% | 147 |
|
|
2022
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 404 |
|
|
2022
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 390 |
|
|
2021
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 358 |
|
|
2021
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 348 |
|
|
2021
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 371 |
|
|
2021
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 347 |
|
|
2020
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 323 |
|
|
2020
Q3 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 298 |
|
|
2019
Q4 | – | Sell |
-37
| Closed | -$3K | – | 324 |
|
|
2019
Q3 | $3K | Buy |
+37
| New | +$3K | 0.01% | 237 |
|